Supernus Pharmaceuticals, Inc.
(SUPN - NASDAQ)
49,46 USD
📋 Profilo Aziendale

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.

|